Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Pharma Companies Pressed To Give Up Patents On Potential COVID-19 Treatments; Gates Foundation, Wellcome To Fund Drug Trials; U.S. Signs Deal With Companies To Produce Potential Vaccines

AFP/France 24: NGOs press drug firm Gilead over potential virus treatment (3/30). Financial Times: Big drugmakers under pressure to share patents against coronavirus (Mancini, 3/31). Financial Times: Gates Foundation and Wellcome Trust to fund Covid-19 drug trials (Kuchler, 3/30). Reuters: J&J, Moderna sign deals with U.S. to produce possible coronavirus…

Editorials, Opinion Pieces Examine Various Aspects Of COVID-19 Pandemic

Wall Street Journal: The Real Cure for Coronavirus Editorial Board “Governments are frantically trying to contain and combat the coronavirus, and those efforts are important, but the world’s best hope is private innovation. Cutting-edge diagnostic tests and treatments are advancing, and government should encourage the trend. President Trump recently ordered…

Editorials, Opinion Pieces Discuss Various Aspects Of Ongoing COVID-19 Pandemic

The Lancet: COVID-19: learning from experience Editorial Board “…[M]any countries are still not following WHO’s clear recommendations on containment (widespread testing, quarantine of cases, contact tracing, and social distancing) and have instead implemented haphazard measures … Alongside the deep distress felt as many countries experience a peak in cases or…

More News In Global Health

Devex: Data mapping key to track disease spread and plug health gaps, experts say (Willmer, 3/26). The Economist: Taking people’s temperatures can help fight the coronavirus (3/26). The Lancet Infectious Diseases: New guidelines for latent tuberculosis (Mushtaq, 4/1). The Lancet Infectious Diseases: Ebola virus disease in DR Congo (Burki, 4/1).…

News Outlets Examine Global Efforts To Develop Coronavirus Treatments, Vaccines

Financial Times: The global hunt for a coronavirus drug | Free to read (Kuchler et al., 3/26). Financial Times: Gilead asks to rescind special status for potential coronavirus drug (Mancini et al., 3/25). Nature: How blood from coronavirus survivors might save lives (Maxmen, 3/24). NBC: Tracking the development of coronavirus…